Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.
暂无分享,去创建一个
P. Comoglio | S. Giordano | M. Mazzone | Silvia Giordano | Massimiliano Mazzone | Paolo M Comoglio | S. Pennacchietti | P. Michieli | M. Galluzzo | Paolo Michieli | Selma Pennacchietti | Maria Galluzzo | Selma Pennacchietti
[1] P. Comoglio,et al. Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF. , 1998, Journal of cell science.
[2] T. Nakamura,et al. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Blagosklonny. Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy (review). , 2001, International journal of oncology.
[4] W. Birchmeier,et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. , 1992, The EMBO journal.
[5] K. Matsumoto,et al. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. , 1993, The Journal of biological chemistry.
[6] D. Gomez,et al. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. , 1999, European journal of biochemistry.
[7] W. Linehan,et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas , 1999, Oncogene.
[8] M. Tsao,et al. Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. , 1992, Oncogene.
[9] W. Risau,et al. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. , 1997, The Biochemical journal.
[10] G. V. Vande Woude,et al. Met-HGF/SF: tumorigenesis, invasion and metastasis. , 2007, Ciba Foundation symposium.
[11] J. Bruix,et al. c‐met mRNA overexpression in human hepatocellular carcinoma , 1994, Hepatology.
[12] D. Mottet,et al. HIF‐1 and AP‐1 Cooperate to Increase Gene Expression in Hypoxia: Role of MAP Kinases , 2001, IUBMB life.
[13] T. Sanchez-Elsner,et al. Endoglin Expression Is Regulated by Transcriptional Cooperation between the Hypoxia and Transforming Growth Factor-β Pathways* , 2002, The Journal of Biological Chemistry.
[14] P. Vaupel,et al. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.
[15] M. Norris,et al. Hypoxia-induced Protein Binding to O2-responsive Sequences on the Tyrosine Hydroxylase Gene (*) , 1995, The Journal of Biological Chemistry.
[16] P. Comoglio,et al. Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas , 2000, Oncogene.
[17] L. Naldini,et al. The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation , 1991, Molecular and cellular biology.
[18] R. Hill,et al. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[19] E. Rofstad,et al. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. , 2002, Cancer research.
[20] J. Rubin,et al. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. , 1993, Biochimica et biophysica acta.
[21] P. Comoglio,et al. EXPRESSION OF Met PROTEIN IN THYROID TUMOURS , 1996, The Journal of pathology.
[22] R. Klausner,et al. The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells , 1999, Molecular and Cellular Biology.
[23] W. Birchmeier,et al. Hepatocyte growth factor/scatter factor induces a variety of tissue- specific morphogenic programs in epithelial cells , 1995, The Journal of cell biology.
[24] M. Noble,et al. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros , 1995, The Journal of cell biology.
[25] D. Seol,et al. Transcriptional activation of the Hepatocyte Growth Factor receptor (c-met) gene by its ligand (Hepatocyte Growth Factor) is mediated through AP-1 , 2000, Oncogene.
[26] A. Bardelli,et al. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists , 1999, Oncogene.
[27] E. Gherardi,et al. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[28] G. Semenza,et al. HIF-1, O2, and the 3 PHDs How Animal Cells Signal Hypoxia to the Nucleus , 2001, Cell.
[29] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[30] M. Sharpe,et al. Scatter factor/hepatocyte growth factor is essential for liver development , 1995, Nature.
[31] M. Shin,et al. Expression of HGF/SF and Met protein is associated with genetic alterations of VHL gene in primary renal cell carcinomas , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[32] J. Pouysségur,et al. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. , 2000, The Journal of biological chemistry.
[33] G. Merlino,et al. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[35] M. Goldberg,et al. Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*) , 1995, The Journal of Biological Chemistry.
[36] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[37] L. Liotta,et al. General mechanisms of metastasis , 1997, Cancer.
[38] H. Lyng,et al. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. , 1998, British Journal of Cancer.
[39] D. Hedley,et al. Hypoxia-inducible Factor-1 (cid:1) Is an Intrinsic Marker for Hypoxia in Cervical Cancer Xenografts 1 , 2022 .
[40] K. Miyazawa,et al. Proteolytic activation of hepatocyte growth factor in response to tissue injury. , 1994, The Journal of biological chemistry.
[41] L. Trusolino,et al. Invasive growth: from development to metastasis. , 2002, The Journal of clinical investigation.
[42] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[43] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.
[44] P. Accornero,et al. K252a inhibits the oncogenic properties of Met, the HGF receptor , 2002, Oncogene.
[45] E. Gherardi,et al. Regulation of cell movement: the motogenic cytokines. , 1991, Biochimica et biophysica acta.
[46] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[47] L. Schmidt,et al. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. , 1999, Cancer research.
[48] M. Stella,et al. Ets up-regulates MET transcription. , 1996, Oncogene.
[49] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[50] G. Semenza,et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.
[51] L. Orci,et al. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor , 1991, Cell.
[52] K. Matsumoto,et al. HGF: its organotrophic role and therapeutic potential. , 1997, Ciba Foundation symposium.
[53] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[54] M. Dewhirst,et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.
[55] George M. Hilliard,et al. Cobalt Inhibits the Interaction between Hypoxia-inducible Factor-α and von Hippel-Lindau Protein by Direct Binding to Hypoxia-inducible Factor-α* , 2003, The Journal of Biological Chemistry.
[56] K. Tashiro,et al. Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.
[57] W. Birchmeier,et al. Role of HGF/SF and c-Met in morphogenesis and metastasis of epithelial cells. , 1997, Ciba Foundation symposium.
[58] Richard D Klausner,et al. The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. , 2002, Cancer cell.
[59] A. Bardelli,et al. A Peptide Representing the Carboxyl-terminal Tail of the Met Receptor Inhibits Kinase Activity and Invasive Growth* , 1999, The Journal of Biological Chemistry.
[60] D. Hicklin,et al. Effect of p53 Status on Tumor Response to Antiangiogenic Therapy , 2002, Science.
[61] A. Bardelli,et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway , 1998, Nature.
[62] J. Sleeman,et al. CD44 is required for two consecutive steps in HGF/c-Met signaling. , 2002, Genes & development.
[63] S. Giordano,et al. Structure and inducible regulation of the human MET promoter. , 1994, The Journal of biological chemistry.
[64] C. Graham,et al. Oxygen-mediated Regulation of Tumor Cell Invasiveness , 2002, The Journal of Biological Chemistry.
[65] M. Surani,et al. Co-expression of the HGF/SF and c-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis. , 1996, Developmental genetics.
[66] M. Dewhirst,et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.
[67] S. Frisch,et al. Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.
[68] W. Birchmeier,et al. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland , 1995, The Journal of cell biology.
[69] M. Pierotti,et al. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. , 1992, Oncogene.
[70] K. Webster,et al. Molecular Regulation of the Endothelin-1 Gene by Hypoxia , 2001, The Journal of Biological Chemistry.
[71] R. Hill,et al. Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. , 1990, Journal of the National Cancer Institute.
[72] J. Folkman. Angiogenesis research: from laboratory to clinic. , 1999, Forum.
[73] Giorgio F. Gilestro,et al. The Semaphorin 4D receptor controls invasive growth by coupling with Met , 2002, Nature Cell Biology.
[74] Tetsuo Noda,et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor , 1995, Nature.
[75] L. Trusolino,et al. Scatter-factor and semaphorin receptors: cell signalling for invasive growth , 2002, Nature Reviews Cancer.
[76] L. Tacchini,et al. Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. , 2001, Carcinogenesis.
[77] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[78] R. Hill,et al. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. , 2001, Cancer research.
[79] L. Trusolino,et al. A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive Growth , 2001, Cell.
[80] E Medico,et al. The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro. , 1996, Molecular biology of the cell.
[81] M. Stella,et al. Cross-talk between the proto-oncogenes Met and Ron , 2000, Oncogene.
[82] G. Hannon. RNA interference : RNA , 2002 .
[83] F. Galimi,et al. Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. , 1994, The Journal of biological chemistry.
[84] Michael Stoker,et al. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility , 1987, Nature.
[85] B. Nordlinger,et al. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[86] J M Brown,et al. Tumor hypoxia, drug resistance, and metastases. , 1990, Journal of the National Cancer Institute.
[87] W. Birchmeier,et al. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis , 1996, Nature.
[88] I. Macdonald,et al. Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.
[89] A. Maity,et al. Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia. , 2000, Experimental cell research.
[90] P. Vaupel,et al. Hypoxic cervical cancers with low apoptotic index are highly aggressive. , 1999, Cancer research.
[91] Q. Xu,et al. Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium , 2000, The Journal of Biological Chemistry.
[92] Kunio Matsumoto,et al. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor , 1998, Oncogene.
[93] N. Ferrara,et al. Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes , 1997, The Journal of Biological Chemistry.
[94] M. Lyon,et al. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. , 1994, The Journal of biological chemistry.
[95] M. Makuuchi,et al. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. , 2000, Blood.
[96] E. Medico,et al. Generation of a truncated hepatocyte growth factor receptor in the endoplasmic reticulum. , 1994, The Journal of biological chemistry.
[97] H. Augustin,et al. A novel vascular endothelial growth factor encoded by Orf virus, VEGF‐E, mediates angiogenesis via signalling through VEGFR‐2 (KDR) but not VEGFR‐1 (Flt‐1) receptor tyrosine kinases , 1999, The EMBO journal.